# The Genomic Data Universe: Understanding the Landscape

## The Data Goldmine: Scale and Scope

### Flagship Datasets (The Heavy Hitters)
**1000 Genomes Project**: The foundation layer
- 2,500+ individuals, global populations
- Comprehensive variant catalog (SNPs, indels, SVs)
- **Impact**: Reference standard for human genetic variation

**UK Biobank**: The clinical jackpot  
- 500K participants with deep phenotyping
- Genotyping + health records + lifestyle data
- **Value**: Largest consented population cohort for research

**gnomAD**: The frequency reference
- Aggregated exome/genome data from diverse populations
- **Critical Function**: Population allele frequencies for variant interpretation

**TCGA**: The cancer atlas
- 30+ cancer types with multi-omic data
- **Application**: Precision oncology development

### The Infrastructure: Who Hosts the World's Genomes

**INSDC Trilogy** (The Global Backbone):
- **GenBank (NCBI)**: US repository
- **ENA (EMBL-EBI)**: European archive  
- **DDBJ**: Japan's database
- **Key Insight**: Synchronized mirrors ensure global accessibility

**Access Patterns**:
- **Open Access**: Reference genomes, population frequencies
- **Controlled Access**: Individual-level data requires authorization (dbGaP)
- **Federated**: Data stays local, queries travel (emerging model)

## File Format Essentials: The Language of Genomics

### Raw Data Flow
```
FASTQ → SAM/BAM → VCF
(reads) → (alignments) → (variants)
```

**FASTQ**: Raw sequencing reads + quality scores
- **Reality**: Massive files (100GB+ per genome)
- **Challenge**: Quality control, storage, transfer

**SAM/BAM**: Aligned reads to reference genome
- **SAM**: Human-readable text
- **BAM**: Compressed binary (production standard)
- **CRAM**: Ultra-compressed (reference-dependent)

**VCF**: The variant standard
- **Content**: SNPs, indels, structural variants
- **Critical Fields**: Position, reference/alt alleles, genotype, quality
- **Challenge**: Annotation complexity, standardization across callers

### The Storage Economics
**Cost Drivers**:
- Raw FASTQ: ~100GB per genome
- Compressed BAM: ~30GB per genome  
- VCF variants: ~100MB per genome
- **Implication**: Storage costs dominate for large biobanks

**Compression Innovation**:
- CRAM reduces storage 2-3x vs BAM
- Reference-free compression emerging
- **Trade-off**: Compression ratio vs. random access speed

## The Business Intelligence

### Market Dynamics
**Data Generation**: Exponential growth
- Sequencing cost collapse enables population-scale studies
- Clinical adoption accelerating (oncology → rare disease → common disease)

**Access Models**:
- **Open**: Drives innovation, limited to aggregated/reference data
- **Controlled**: Individual-level data, regulatory compliance required
- **Commercial**: 23andMe, UK Biobank → licensing models emerging

**Integration Challenges**:
- **Format Fragmentation**: Different centers, different standards
- **Metadata Inconsistency**: Sample annotation varies wildly
- **Version Control**: Reference genome updates break compatibility

### The Privacy-Performance Tension

**Current Reality**:
- Useful research data requires individual-level information
- Privacy regulations increasingly restrict data sharing
- **Result**: Data silos limit research potential

**The PET Opportunity**:
- Enable analysis on sensitive data without exposure
- Unlock federated learning across biobanks
- **Value Creation**: Privacy compliance → data utility ↑ → research acceleration

## Investment Implications

**Infrastructure Plays**:
- Cloud-native genomic data platforms
- Format standardization and interoperability
- Privacy-preserving federation technologies

**Application Layer**:
- Tools that work across heterogeneous datasets
- Real-time variant interpretation
- Population-scale analytics platforms

**The Moat**: Network effects in data aggregation + privacy-preserving technology stack

**Bottom Line**: Public genomic datasets created the foundation. Private datasets hold the clinical value. PETs are the bridge that unlocks this trapped value at scale.

---
*Data abundance without privacy solutions = innovation scarcity.* 